Multidrug resistance and ESBL-producing Salmonella spp. isolated from broiler processing plants

Abstract

The aim of this study was to investigate the occurrence of multidrug-resistant, extended spectrum beta-lactamase (ESBL) producing Salmonella spp. isolated from conveyor belts of broiler cutting rooms in Brazilian broiler processing plants. Ninety-eight strains of Salmonella spp. were analyzed. Multidrug resistance was determined by the disk diffusion test and the susceptibility of the isolated bacteria was evaluated against 18 antimicrobials from seven different classes. The double disk diffusion test was used to evaluate ESBL production. Of the 98 strains tested, 84 were multidrug resistant. The highest rates of resistance were against nalidixic acid (95%), tetracycline (91%), and the beta-lactams: ampicillin and cefachlor (45%), followed by streptomycin and gentamicin with 19% and 15% of strain resistance, respectively. By contrast, 97% of the strains were sensitive to chloramphenicol. 45% of the strains were positive for the presence of ESBL activity. In this study, high rates of multidrug resistance and ESBL production were observed in Salmonella spp.

Keywords
Antimicrobial resistance; Salmonella spp.; Food borne pathogens

Introduction

Salmonella spp. is one of the main agents responsible for several infections, e.g., food borne gastroenteritis. Most of these infections cause self-limiting diarrhea and do not require antimicrobial treatment. However, in certain cases, such as when the bacterium is spread via blood stream leading to complications such as meningitis, antibiotic therapy is necessary. Such complications are most commonly observed in children and elderly and immune compromised patients. Fluoroquinolones and cephalosporins are the drugs of first-choice in such cases.¹

Food of animal origin, especially poultry derived items, are the main sources of infection by Salmonella spp.² Given the importance to Salmonella spp. as causative agents in food borne diseases, reduction of its contamination on broiler carcasses is of extremely high priority for industry as well as regulatory agencies.³ The occurrence of Salmonella spp. on the broiler carcasses might be a result of contamination either at the farm or cross-contamination within the processing plant.⁴ Cross-contamination can be attributed partly to residual bacteria remaining on surfaces and equipment after sanitization.⁵

Studies on Salmonella spp. are usually focused on analyzing resistance of the bacterium to antimicrobials such as fluoroquinolones; but, in the last decade or so, bacterial production of large spectrum beta-lactamases has also been evaluated.^6,7 In Enterobacteriaceae, resistance to cephalosporins is generally attributed to the production of large spectrum beta-lactamases such as ESBL (extended spectrum beta-lactamase) and AmpC beta-lactamase.⁸ ESBL is the term used for any beta-lactamase that is acquired and not intrinsic to a species. Such lactamases quickly hydrolyze and confer resistance against oxyimino-cephalosporins. Mutant beta-lactamases that have similar activity are also referred to as ESBLs.^9,10

Extensive studies have been undertaken to analyze ESBL production by Klebsiella spp., Enterobacter spp., and Escherichia coli isolated from human clinical samples. These studies are prompted by the lack of therapeutic success against these microorganisms, which includes, but not restricted to, cephalosporins. Treatment is rendered unsuccessful by the acquisition of resistance genes that reside on mobile genetic elements. For example, plasmids that transmit resistance genes for cephalosporins are frequently found to carry resistance to other antibiotics, such as fluoroquinolones.¹¹ Some authors have also reported ESBLs in microorganisms isolated from food products.^12–14 According to Blanc et al. (2006), these findings are more recent in the case of E. coli and Salmonella spp. as compared to Klebsiella spp. and Enterobacter spp. ESBL production by Salmonella spp. isolated from animals has also been reported^15,16; although, the reports on ESBL from animal origin are less frequent.^17,18

Due to the public health risk of cross-contamination, it is important to have sufficient information on the occurrence of pathogens, e.g., Salmonella spp., in the cutting rooms for broiler processing and slaughtering facilities. It is especially important to have knowledge of the behavior of these strains against antimicrobials. Therefore, the objective of this study was to determine the occurrence of multidrug resistant in ESBL-producing Salmonella spp. isolated from conveyor belts in the cutting rooms of broiler processing plants.

Materials and methods

Isolation and identification of Salmonella spp.

Strains of Salmonella spp. were obtained from the cutting rooms of four different Brazilian broiler processing and exporting plants having a slaughtering capacity in excess of 160,000 broilers/day. For the isolation of Salmonella spp. from the surface of the conveyor belts, the sponges (Nasco Whirl-Pak ™), pre-moistened with 10 mL of 0.1% saline peptone water, were utilized on a 400 cm² area. Salmonella spp. detection was carried out according to the Food and Drug Administration (FDA – USA) methodology as published in the Bacteriological Analytical Manual.¹⁹ Subsequent to these tests, isolates of Salmonella spp. were confirmed by genus identification using polymerase chain reaction (PCR) for the sifB gene as per the protocol described by Almeida et al.²⁰

Antimicrobial susceptibility test

The susceptibility to antimicrobials was determined using the agar diffusion test as per the documents M31-A3²¹ and M100-S23²² of the Clinical and Laboratory Standards Institute. Eighteen antimicrobial agents from seven different classes were tested: (1) Beta-lactams, divided into 3 subclasses: (a) Penicillins: ampicillin (AMP; 10 µg), (b) Cephalosporins: cefachlor (CFC; 30 µg) and ceftiofur (CTF; 30 µg), and (c) Carbapenems: meropenem (MER;10 µg) and imipenem (IPM; 10 µg); (2) Aminoglycosides: streptomycin (EST; 10 µg), tobramycin (TOB; 10 µg), gentamycin (GEN; 10 µg), amikacin (AMI; 30 µg) and neomycin (NEO; 30 µg); (3) Quinolones: enrofloxacin (ENO; 5 µg), nalidixic acid (NAL; 30 µg), and ciprofloxacin (CIP; 5 µg); (4) Sulfamethoxazole and Trimethoprim: sulfamethoxazole/trimethoprim (SUT; 25 µg); (5) Tetracyclines: tetracycline (TET; 30 µg); (6) Phenicols: chloramphenicol (CLO; 30 µg) and florfenicol (FLF; 30 µg) and (7) Polymyxins: polymyxin B (POL, 300 UI). Strains were considered multidrug resistant if they were resistant to at least three classes of antimicrobials (at least one antimicrobial of each class).²³ The quality control test was based on E. coli ATCC 25922.

ESBL production

ESBL production was analyzed by the double disk diffusion test.²⁴ The central disk was having amoxicillin plus clavulanic acid (AMX/AC; 20/10 µg). Four other disks were placed within a 20 mm radius of the first one: ceftazidime (CAZ; 30 µg), ceftriaxone (CRO; 30 µg), cefepime (CPM, 30 µg) and aztreonam (ATM; 30 µg).²⁵ Samples were considered positive for ESBL when the inhibition zone around any cephalosporin increased toward the central disk with AMX/AC, and when the inhibition zone around at least one of the cephalosporins was smaller than 19 mm.²⁶

Results

Out of the 98 strains evaluated (26, 23, 19, and 30 from each of the four cutting rooms, respectively), three were sensitive to all antimicrobials tested, four were resistant to one class, seven were resistant to two classes, and 84 (86%) were considered multidrug resistant.

Fig. 1 shows the resistance profiles of the multidrug resistant strains arranged according to the room of origin, and the corresponding percentage profiles in each room. ESBL activity was detected in 45% of the strains. From the strains positive for ESBL production, the most frequent resistance profile was against beta-lactams, quinolones, and tetracyclines (38/44); the ESBL-negative strains were resistant to aminoglycosides, quinolones, and tetracyclines (36/54). The results for Salmonella spp. antimicrobial susceptibility test are presented in Fig. 2.

Fig. 1
Resistance profile of multidrug resistant Salmonella spp. strains as per ESBL analysis and cutting room of origin. * B-LAC, B-lactams; AMI, aminoglycosides; QUI, quinolones; SUT, sulfamethoxazole/trimethoprim; TET, tetracyclines; POL, polymixin.

Fig. 2
Percentages recorded for the antimicrobial susceptibility test of Salmonella spp. strains isolated from cutting rooms of broiler processing plants. AMP, ampicillin; CFC, cephachlor; CTF, ceftiofur; MER, meropenem; IPM, imipenem; EST, streptomycin; TOB, tobramycin; GEN, gentamycin; AMI, amikacin; NEO, neomycin; ENO, enrofloxacin; NAL, nalidixic acid; CIP, ciprofloxacin; SUT, sulfamethoxazole/trimethoprim; TET, tetracycline; CLO, chloramphenicol; FLF, florfenicol; POL, polymyxin B.

The strains, sensitive to all antimicrobials (3/98), originated from Room 3 and represented 16% (3/19) of the total number of strains isolated from this room. The same percentage of resistance was observed for only one or two antimicrobial classes and 52% (10/19) strains were multidrug resistant. However, in Rooms 1, 2, and 4, 100% (26/26), 87% (20/23), and 93% (28/30), respectively, of the Salmonella spp. strains were multidrug resistant. The highest numbers of ESBL-positive strain were isolated from Room 4, corresponding to 54% (24/44) of the positive strains.

Discussion

Recently, incidence of antimicrobial resistance in Salmonella spp. isolated from foods of animal origin, especially poultry products, has increased.^27–29 In this study, all strains were sensitive to ciprofloxacin and 95% of them were resistant to nalidixic acid (Fig. 2). Hamidiam et al.³⁰ suggested that the low in vitro resistance to ciprofloxacin may be due to a mutation in the gyrA gene and that in vitro resistance to nalidixic acid may be used to detect the actual level of resistance to ciprofloxacin. The CLSI²² recommends that resistance to this class of antimicrobials should be considered as collective, that is, resistance to one drug implies that the microorganism is resistant to the whole class. This information is of great importance because fluoroquinolones are considered as the drug of first choice for the treatment of infections caused by Salmonella spp. in human.³¹

High levels of resistance were also observed against tetracycline (Fig. 2). Worldwide incidence of resistance in Salmonella spp. isolated from the poultry production chain is variable with percentages ranging from 96.6% to 21.8%.^32–34 In Brazil, Oliveira et al.³⁵ reported low resistance indexes in Salmonella Enteritidis isolated from humans, poultry carcasses, poultry-related samples, and food items involved in food borne disease outbreaks in the southern region of the country.

Additionally, 97% of the strains tested were sensitive to chloramphenicol (Fig. 2), which is one of the first drugs used in veterinary medicine and which has been banned from animal production in Brazil since 1998.³⁶ The use of tetracycline as a growth promoter in poultry production is also prohibited in Brazil.³⁷

All strains were sensitive to the carbapenems tested; this is an important finding because carbapenems are the drugs of first choice in the treatment of ESBL-producing microorganisms.³⁸ ESBL production was detected in 45% (44/98) of the strains. These ESBL-positive strains were also multidrug resistant. Clemente et al. ¹⁷ analyzed 1120 isolates of Salmonella spp. from food items of animal origin and found only five ESBL-producing strains. However, they used a methodology that was different from the present one. Nogueira-Miranda et al.¹⁰ compared six methodologies for the detection of ESBL in Enterobacter spp. and concluded that the double disk diffusion test showed sensitivity of 89.2% and specificity of 100% for this species. Due to the absence of a standard methodology approved by any of the international committees for the evaluation of Salmonella spp., ESBL production may result in underestimation of the occurrence of this phenotype. It is also difficult to compare different studies. The phenotypic confirmatory tests are highly sensitive and specific as compared to the genotypic confirmatory tests.³⁹ This study was aimed to screen ESBL producing organisms. Further research is required for the genotypic characterization of ESBL-producing Salmonella spp. found in broiler processing plants.

In conclusion, the present study demonstrated multidrug resistance in 86% and ESBL activity in 45% of the Salmonella spp. isolated from the studied broiler processing plants. These results should be taken as a precautionary warning for the spread of multidrug resistant Salmonella spp. in broiler production industry.

• Associate Editor: Eduardo Cesar Tondo

Acknowledgment

We are grateful to Laboratório de Inspeção e Controle de Qualidade de Alimentos e Água, Universidade Federal do Paraná (UFPR) for subsidizing the purchase materials for this study.

References

• ¹
  Miriagou V,Tassios PT, Legakis NJ, Tzouvelekis LS. Expanded-spectrum cephalosporin resistance in non-typhoid Salmonella. Int J Antimicrob Agents 2004;23:547-555.
• ²
  Greig JD, Ravel A. Analysis of foodborne outbreak data reported internationally for source attribution. Int J Food Microbiol 2009;130:77-87.
• ³
  Berrang ME, Bailey JS, Altekruse SF, et al. Prevalence, serotype, and antimicrobial resistance of Salmonella on broiler carcasses postpick and postchill in 20 U.S. processing plants. J Food Prot 2009;72:1610-1615.
• ⁴
  Rasschaert G, Houf K, Godard C, Wildemauwe C, Pastuszczak-Frak M, De Zutter L. Contamination of carcasses with Salmonella during poultry slaughter. J Food Prot 2008;71:146-152.
• ⁵
  Rasschaert G, Houf K, De Zutter L. Impact of the slaughter line contamination on the presence of Salmonella on broiler carcasses J Appl Microbiol 2007;103:333-341.
• ⁶
  Threlfall EJ. Antimicrobial drug resistance in Salmonella: problems and perspectives in food- and water-borne infections. FEMS Microbiol Rev 2002;26:141-148.
• ⁷
  Li XZ, Mehrotra M, Ghimire S, Adewoye L. Beta-lactam resistance and beta-lactamases in bacteria of animal origin. Vet Microbiol 2007;121:197-214.
• ⁸
  de Jong A, Smet A, Ludwig C, et al. Antimicrobial susceptibility of Salmonella isolates from healthy pigs and chickens (2008-2011). Vet Microbiol 2014;171:298-306.
• ⁹
  Livermore DM. Defining an extended-spectrum beta-lactamase. Clin Microbiol Infect 2008;14(suppl 1):3-10.
• ¹⁰
  Nogueira-Miranda KS, Palmeiro JK, Conte D, et al. Detection of extended-spectrum p-lactamase in Enterobacter spp. -evaluation of six phenotypic tests. Microb Drug Resist 2012;18:66-70.
• ¹¹
  Nogueira KS, Paganini MC, Conte A, et al. Emergence of extended-spectrum p-lactamase producing Enterobacter spp. in patients with bacteremia in a tertiary hospital in southern Brazil. Enferm Infecc Microbiol Clin 2014;32:87-92.
• ¹²
  Cohen Stuart J, van den Munckhof T, Voets G, Scharring J, Fluit A, Hall MLV. Comparison of ESBL contamination in organic and conventional retail chicken meat. Int J Food Microbiol 2012;154:212-214.
• ¹³
  Ryu SH, Lee JH, Park SH, et al. Antimicrobial resistance profiles among Escherichia coli strains isolated from commercial and cooked foods. Int J Food Microbiol 2012;159:263-266.
• ¹⁴
  Ojer-Usoz E, González D, Vitas AI, et al. Prevalence of extended-spectrum p-lactamase-producing Enterobacteriaceae in meat products sold in Navarra, Spain. 28. Meat Sci 2013;93:316-321.
• ¹⁵
  Clemente L, Correia I, Themudo P, Neto I, Canica M, Bernardo F. Antimicrobial susceptibility of Salmonella enterica isolates from healthy breeder and broiler flocks in Portugal. Vet J 29. 2014;200:276-281.
• ¹⁶
  Jiang HX, Song L, Liu J, et al. Multiple transmissible genes encodin fluoroquinolone and third-generation cephalosporin resistance co-located in non-typhoidal Salmonella isolated from food-producing animals in China. 30. Int J Antimicrob Agents 2014;43:242-247.
• ¹⁷
  Clemente L, Manageiro VFerreira E, et al. Occurrence of extended-spectrum p-lactamases among isolates of Salmonella enterica subsp. enterica from food-producing animals and food products, in Portugal. IntJ Food Microbiol 31. 2013;167:221-228.
• ¹⁸
  Egervarn M, Borjesson S, Byfors S, et al. Escherichia coli with extended-spectrum beta-lactamases or transferable AmpC beta-lactamases and Salmonella on meat imported into Sweden. IntJ Food Microbiol 2014;171:8-14.
• ¹⁹
  Andrews W Hammack T. Salmonella In: Bacteriological 32. Analytical Manual [s.l. ] U.S. Food and Drug Administration; 2007.
• ²⁰
  de Almeida MV, Silva A Jr, Nero LA. Evaluation of target sequences for the polymerase chain reaction-based 33. detection of Salmonella in artificially contaminated beef. Foodborne Pathog Dis 2014;11:111-118.
• ²¹
  CLSI. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. Aproved 34. Standard. CLSI Document M31-A3 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
• ²²
  CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 23rd Informational Supplement. CLSI Document 35. M100-S23 Wayne, PA: Clinical and Laboratory Standards Institute; 2013.
• ²³
  Ngoi ST, Thong KL. Molecular characterization showed limited genetic diversity among Salmonella Enteritidis isolated from humans and animals in Malaysia. Diagn Microbiol Infect 36. Dis 2013;77:304-311.
• ²⁴
  Pitout JDD, Reisbig MD, Venter EC, Church DL, Hanson ND. Modification of the double-disk test for detection of enterobacteriaceae producing extended-spectrum and AmpC p-lactamases. J Clin Microbiol 2003;41:3933-3935.
• ²⁵
  Sousa MA Jr, Ferreira EV, Conceicão GC. Betalactamase de 37. espectro estendido (ESBL): um importante mecanismo de resistência bacteriana e sua deteccão no laboratório clínico. NewsLab 2004;63:152-174.
• ²⁶
  EUCAST. European Committee on Antimicrobial Susceptibility 38. Testing Guidelines for Detection of Resistance Mechanisms andSpecific Resistances of Clinical and/or Epidemiological Importance 39. European Society of Clinical Microbiology and Infectious Diseases: Sweden; 2013.
• ²⁷
  Antunes P Réu C, Sousa JC, Peixe L, Pestana N. Incidence of Salmonella from poultry products and their susceptibility to antimicrobial agents. Int J Food Microbiol 2003;82:97-103.
• ²⁸
  Hur J, Kim JH, Park JH, Lee YJ, Lee JH. Molecular and virulence characteristics of multi-drug resistant Salmonella Enteritidis strains isolated from poultry. Vet J 2011;189:306-311.
• ²⁹
  Bacci C, Boni E, Alpigiani I, Lanzoni E, Bonardi S, Brindani F. Phenotypic and genotypic features of antibiotic resistance in Salmonella enterica isolated from chicken meat and chicken and quail carcasses. IntJ Food Microbiol 2012;160:16-23.
• ³⁰
  Hamidian M, Tajbakhsh M, Tohidpour A, Rahbar M, Zali MR, Walther-Rasmussen J. Detectio of novel gyrA mutations in nalidixic acid-resistant isolates of Salmonella enterica from patients with diarrhoea. Int J Antimicrob Agents 2011;37:360-364.
• ³¹
  Pokharel BM, Koirala J, Dahal RK, Mishra SK, Khadga PK, Tuladhar NR. Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives. Int J Infect Dis 2006;10:434-438.
• ³²
  Manie T, Khan S, Broze VS, Veith WJ, Gouws PA. Antimicrobial resistance of bacteria isolated from slaughtered and retail chickens in South Africa. Lett Appl Microbiol 1998;26:253-258.
• ³³
  Carramrnana JJ, Rota C, Agustín I, Herrera A. High prevalence of multiple resistance to antibiotics in Salmonella serovars isolated from a poultry slaughterhouse in Spain. Vet Microbiol 2004;104:133-139.
• ³⁴
  Tha TH, Hirai T, Lan NT, Yamaguchi R. Antibiotic resistance profiles of Salmonella serovars isolated from retail pork and chicken meat in North Vietnam. Int J Food Microbiol 2012;156:147-151.
• ³⁵
  Dias de Oliveira S, Siqueira Flores F dos Santos LR, Brandelli A. Antimicrobial resistance in Salmonella enteritidis strains isolated from broiler carcasses, food, human and poultry-related samples. IntJ Food Microbiol 2005;97:297-305.
• ³⁶
  Brasil. Portaria n. 448, de 10 de setembro de 1998. Dispõe sobre a proibição de fabricação, importação, comercialização e o emprego de preparações farmacêuticas de uso veterinário, de rações, e de aditivos alimentares que especifica e revoga a portaria que menciona. Ministério da Agricultura e Abastecimento, Brasília; 1998.
• ³⁷
  Brasil. Portaria n° 159, de 23 de junho de 1992. Dispõe sobre a proibição do uso de clortetraciclina, oxitetraciclina e penicilina como promotores de crescimento. Ministério da Agricultura e Abastecimento, Brasília.
• ³⁸
  Zhanel GG, Wiebe R, Dilay L, et al. Comparative review of the carbapenems. Drugs 2007;67:1027-1052.
• ³⁹
  Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005;18:657-686.

Publication Dates

• Publication in this collection
  Jan-Mar 2016

History

• Received
  16 Dec 2014
• Accepted
  24 July 2015